Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 27, 2008HaematologicaOpen Access

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

View Full Paper
Ask AI
Bookmark
Share

Authors

FPFlora PeyvandiBroad InstituteSLSilvia LavoretanoUniversity of MilanRPRoberta PallaUniversity of Pisa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Peyvandi et al. (2008) studied this question.

synapsesocial.com/papers/6a870d04a810ea404bcfa207https://doi.org/10.3324/haematol.11739
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1von Willebrand factor cleaving protease (ADAMTS‐13) and ADAMTS‐13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura2004 · 159 citations
  2. 2Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA)2006 · 100 citations
  3. 3Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity2006 · 298 citations
  4. 4Late Relapses in Patients Successfully Treated for Thrombotic Thrombocytopenic Purpura1995 · 176 citations
  5. 5von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome2002 · 192 citations